Stay at home mandates and social distancing has created a near shut down in clinical safety testing and performance testing that rely on in-person visits from study participants. Testing is a critical asset for ensuring product safety, substantiating claims, legal and regulatory risk mitigation and ensuring successful product launches. In this special report, The Benchmarking Company offers recommendations to proactively manage several testing  scenarios.